Recombinant Zoster Vaccine (CHO Cell) LYB004
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Zoster Vaccine (CHO Cell) LYB004, covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older [Phase 2]